To assess the metabolic activity of HepG2 cells via human serum (HS) supplementation and compare it with Huh7 cells in terms of enzyme expression and metabolite formation.
Key Findings:
HS supplementation improved mRNA and protein levels of drug-metabolizing enzymes, including CYP3A4 and CYP2D6, in HepG2 cells.
Huh7 cells showed increased metabolic activity with HS compared to FBS.
Direct measurement of metabolite formation provided a more relevant assessment of metabolic capacity.
Interpretation:
Human serum supplementation enhances the metabolic capacity of hepatoma cell lines, making them more representative of human liver function.
Limitations:
The study did not explore the long-term effects of HS supplementation on cell viability.
Potential variability in serum composition could affect reproducibility and may lead to inconsistent results across experiments.
Conclusion:
Human serum is a viable alternative to fetal bovine serum for enhancing the metabolic activity of hepatoma cell lines in toxicology research.
